NCT01769547 A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy Status TERMINATED Phase PHASE2
NCT01766778 Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Status COMPLETED Phase PHASE4
NCT01762761 Eltrombopag Phase III Study In Chinese Chronic ITP Patients Status COMPLETED Phase PHASE3
NCT01760525 A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01758380 Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan Status COMPLETED Phase PHASE4
NCT01757691 Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON) Status TERMINATED Phase PHASE2
NCT01757015 Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS Status WITHDRAWN Phase PHASE3
NCT01755871 Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis Status TERMINATED Phase PHASE4
NCT01753323 Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection Status COMPLETED Phase PHASE2
NCT01752634 Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01750918 BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) Status COMPLETED Phase PHASE1/PHASE2
NCT01747876 Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma Status TERMINATED Phase PHASE1
NCT01744665 A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Status COMPLETED Phase PHASE2
NCT01744028 Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool. Status COMPLETED Phase PHASE1
NCT01743989 A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML. Status COMPLETED Phase PHASE3
NCT01743560 An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis Status COMPLETED Phase PHASE4
NCT01742299 Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator Status COMPLETED Phase PHASE4
NCT01742286 Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Status COMPLETED Phase PHASE1
NCT01740648 Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer Status COMPLETED Phase PHASE1